Literature DB >> 9764591

Seventeen-year evaluation of breast cancer screening: the DOM project, The Netherlands. Diagnostisch Onderzoek (investigation) Mammacarcinoom.

G A Miltenburg1, P H Peeters, J Fracheboud, H J Collette.   

Abstract

The DOM project is a non-randomized population-based breast cancer screening programme in Utrecht which started in 1974-75. The 17-year effect has been evaluated by a case-control study of breast cancer deaths during the period 1975-92 in women living in the city of Utrecht, born between 1911 and 1925, whose breast cancers were diagnosed after the initiation of the DOM project. Controls (three for each case) were defined as women having the same year of birth as the case, living in the city of Utrecht at the time the case died, and having had the opportunity of screening in the DOM project. Screening in the period 1975-92 indicated a breast cancer mortality reduction of 46% (odds ratio of 0.54, 95% confidence interval 0.37-0.79). The strongest protective effect was found at a screening interval of 2 years or less (mortality reduction of 62%, odds ratio of 0.38), and for the highest number of screens (mortality reduction of 68%, odds ratio of 0.32 for more than four screens). Exclusion of breast cancer deaths that occurred within 1 year of diagnosis, to allow for 'lead-time' bias, gave an odds ratio of 0.61. Early diagnosis of breast cancer by screening reduces breast cancer mortality in the long term. Bias due to the study design may slightly overestimate the protective effect. A screening programme with a 2-yearly, or smaller, interval between successive screens will improve the protection of screening.

Entities:  

Mesh:

Year:  1998        PMID: 9764591      PMCID: PMC2063114          DOI: 10.1038/bjc.1998.609

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Evaluation of a breast cancer screening programme--the DOM project.

Authors:  C Collette; H J Collette; J Fracheboud; B J Slotboom; F de Waard
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

2.  NHS breast screening programme: is the high incidence of interval cancers inevitable?

Authors:  D Asbury; C R Boggis; D Sheals; A G Threlfall; C B Woodman
Journal:  BMJ       Date:  1996-11-30

3.  Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study.

Authors:  H J Collette; N E Day; J J Rombach; F de Waard
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

4.  Revision of "NHS breast screening: the facts": an evaluation.

Authors:  J Patnick; J Austoker; T Wolff
Journal:  J Med Screen       Date:  1995       Impact factor: 2.136

5.  Bias in case-control studies of screening effectiveness.

Authors:  R S Hosek; W D Flanders; A J Sasco
Journal:  Am J Epidemiol       Date:  1996-01-15       Impact factor: 4.897

6.  Attempts to evaluate a non-randomized breast cancer screening programme (the 'DOM-project').

Authors:  H J Collette
Journal:  Maturitas       Date:  1985-05       Impact factor: 4.342

7.  The DOM project for the early detection of breast cancer, Utrecht, The Netherlands.

Authors:  F de Waard; H J Collette; J J Rombach; E A Baanders-van Halewijn; C Honing
Journal:  J Chronic Dis       Date:  1984

8.  Further evidence of benefits of a (non-randomised) breast cancer screening programme: the DOM project.

Authors:  H J Collette; F de Waard; J J Rombach; C Collette; N E Day
Journal:  J Epidemiol Community Health       Date:  1992-08       Impact factor: 3.710

9.  Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.

Authors:  L Tabar; G Fagerberg; H H Chen; S W Duffy; C R Smart; A Gad; R A Smith
Journal:  Cancer       Date:  1995-05-15       Impact factor: 6.860

10.  Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.

Authors:  H J de Koning; R Boer; P G Warmerdam; P M Beemsterboer; P J van der Maas
Journal:  J Natl Cancer Inst       Date:  1995-08-16       Impact factor: 13.506

View more
  5 in total

Review 1.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

2.  Sensitivity and specificity of mammographic screening as practised in Vermont and Norway.

Authors:  S Hofvind; B M Geller; J Skelly; P M Vacek
Journal:  Br J Radiol       Date:  2012-09-19       Impact factor: 3.039

3.  Breast cancer mortality in relation to receipt of screening mammography: a case-control study in Saskatchewan, Canada.

Authors:  Gaia Pocobelli; Noel S Weiss
Journal:  Cancer Causes Control       Date:  2014-12-04       Impact factor: 2.506

4.  Screen-detected breast cancers have a lower mitotic activity index.

Authors:  R P Groenendijk; P Bult; L Tewarie; P G Peer; R F van der Sluis; T J Ruers; T Wobbes
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

5.  A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality.

Authors:  P C Allgood; J Warwick; R M L Warren; N E Day; S W Duffy
Journal:  Br J Cancer       Date:  2007-12-04       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.